Breaking News Instant updates and real-time market news.

ECOM

ChannelAdvisor

$28.22 /

+1.24 (+4.60%)

07:20
09/20/21
09/20
07:20
09/20/21
07:20

ChannelAdvisor price target raised to $35 from $31 at Needham

Needham analyst Joshua Reilly raised the firm's price target on ChannelAdvisor to $35 from $31 and keeps a Buy rating on the shares after meeting with its management at the ChannelAdvisor Virtual Analyst Day. The analyst maintains his view of a "sustainable low double-digit growth" as the base case for the company exiting the pandemic, with its Brands customer revenue increases in the overall mix. Reilly adds that ChannelAdvisor's Brands customers' unit economics are superior to retail customers', and their ability to purchase the entire suite of products "presents a larger opportunity".

ECOM ChannelAdvisor
$28.22 /

+1.24 (+4.60%)

02/12/21 B. Riley
ChannelAdvisor price target raised to $36 from $30 at B. Riley Securities
02/09/21 B. Riley
ChannelAdvisor price target raised to $30 from $24.50 at B. Riley Securities
11/05/20 Baird
ChannelAdvisor price target lowered to $18 from $20 at Baird
10/16/20
Fly Intel: Top five analyst upgrades

TODAY'S FREE FLY STORIES

Upgrade
Concentric upgraded to Buy from Hold at Kepler Cheuvreux » 05:10
10/27/21
10/27
05:10
10/27/21
05:10
CCNTF

Concentric

$22.92 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCNTF Concentric
$22.92 /

+ (+0.00%)

10/18/21 Danske Bank
Concentric upgraded to Buy from Hold at Danske Bank
Downgrade
Xtep downgraded to Underperform from Outperform at KGI Securities » 05:09
10/27/21
10/27
05:09
10/27/21
05:09
XTEPY

Xtep

$127.58 /

+ (+0.00%)

KGI Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XTEPY Xtep
$127.58 /

+ (+0.00%)

04/15/21 HSBC
Xtep downgraded to Hold from Buy at HSBC
Downgrade
Li Ning downgraded to Underperform from Neutral at KGI Securities » 05:09
10/27/21
10/27
05:09
10/27/21
05:09
LNNGY

Li Ning

$304.56 /

+1.16 (+0.38%)

KGI Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Anta Sports downgraded to Underperform from Neutral at KGI Securities » 05:08
10/27/21
10/27
05:08
10/27/21
05:08
ANPDY

Anta Sports Products

$405.69 /

-10.31 (-2.48%)

KGI Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANPDY Anta Sports Products
$405.69 /

-10.31 (-2.48%)

10/11/21 JPMorgan
Anta Sports Products downgraded to Neutral from Overweight at JPMorgan
12/11/20 Citi
Citi opens 'Negative Catalyst Watch' on Anta Sports Products
Hot Stocks
Illumina enters agreement with Israel MoH for WGS pilot program » 05:08
10/27/21
10/27
05:08
10/27/21
05:08
ILMN

Illumina

$417.00 /

-3.37 (-0.80%)

Illumina announced an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$417.00 /

-3.37 (-0.80%)

ILMN Illumina
$417.00 /

-3.37 (-0.80%)

10/14/21 Cowen
Illumina coverage transferred at Cowen
10/01/21 OTR Global
Illumina view downgraded to Mixed from Positive at OTR Global
08/31/21 Canaccord
Illumina acquisition of GRAIL dilutive for several years, says Canaccord
08/23/21 Canaccord
Illumina FTC probe of GRAIL not surprising, says Canaccord
ILMN Illumina
$417.00 /

-3.37 (-0.80%)

ILMN Illumina
$417.00 /

-3.37 (-0.80%)

ILMN Illumina
$417.00 /

-3.37 (-0.80%)

ILMN Illumina
$417.00 /

-3.37 (-0.80%)

Upgrade
Abbott upgraded to Overweight from Neutral at Atlantic Equities » 05:07
10/27/21
10/27
05:07
10/27/21
05:07
ABT

Abbott

$128.13 /

+1.51 (+1.19%)

Atlantic Equities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABT Abbott
$128.13 /

+1.51 (+1.19%)

ABT Abbott
$128.13 /

+1.51 (+1.19%)

10/21/21 Morgan Stanley
Abbott price target raised to $146 from $136 at Morgan Stanley
10/21/21 Raymond James
Abbott price target raised to $134 from $128 at Raymond James
10/14/21 Redburn
Abbott initiated with a Neutral at Redburn
10/04/21 Cowen
Abbott Q3 results not likely to contain sales warning, says at Cowen
ABT Abbott
$128.13 /

+1.51 (+1.19%)

ABT Abbott
$128.13 /

+1.51 (+1.19%)

ABT Abbott
$128.13 /

+1.51 (+1.19%)

ABT Abbott
$128.13 /

+1.51 (+1.19%)

Initiation
Redbox initiated with a Buy at B. Riley » 05:06
10/27/21
10/27
05:06
10/27/21
05:06
RDBX

Redbox

$15.76 /

+4.06 (+34.70%)

B. Riley initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDBX Redbox
$15.76 /

+4.06 (+34.70%)

RDBX Redbox
$15.76 /

+4.06 (+34.70%)

Downgrade
Hannover Re downgraded to Hold from Buy at Societe Generale » 05:06
10/27/21
10/27
05:06
10/27/21
05:06
HVRRY

Hannover Re

$91.21 /

+1.52 (+1.69%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HVRRY Hannover Re
$91.21 /

+1.52 (+1.69%)

10/21/21 Societe Generale
Hannover Re downgraded to Hold from Buy at Societe Generale
10/20/21 Credit Suisse
Hannover Re price target lowered to EUR 172 from EUR 174 at Credit Suisse
10/15/21 Barclays
Hannover Re price target raised to EUR 133.30 from EUR 131.20 at Barclays
09/10/21 Barclays
Hannover Re price target lowered to EUR 131.20 from EUR 132.20 at Barclays
Recommendations
Twitter price target lowered to $70 from $76 at Piper Sandler » 05:01
10/27/21
10/27
05:01
10/27/21
05:01
TWTR

Twitter

$61.40 /

-0.71 (-1.14%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$61.40 /

-0.71 (-1.14%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

10/24/21 BofA
Twitter price target lowered to $82 from $90 at BofA
10/22/21 Piper Sandler
Snap results raise uncertainty for digital advertising, says Piper Sandler
10/18/21 Wedbush
Wedbush continues to favor Google, Snap headed into quarterly results
10/07/21 Oppenheimer
AppLovin price target raised to $95 from $75 at Oppenheimer
TWTR Twitter
$61.40 /

-0.71 (-1.14%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

TWTR Twitter
$61.40 /

-0.71 (-1.14%)

Recommendations
Commvault earnings selloff provides opportunity, says Summit Insights » 04:59
10/27/21
10/27
04:59
10/27/21
04:59
CVLT

Commvault

$61.31 /

-14.255 (-18.87%)

Summit Insights analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVLT Commvault
$61.31 /

-14.255 (-18.87%)

CVLT Commvault
$61.31 /

-14.255 (-18.87%)

10/26/21 William Blair
Commvault downgraded to Market Perform from Outperform at William Blair
07/28/21 Summit Insights
Commvault price target raised to $90 from $80 at Summit Insights
07/22/21 KeyBanc
Commvault price target raised to $90 from $85 at KeyBanc
05/12/21 Piper Sandler
Commvault price target raised to $86 from $84 at Piper Sandler
CVLT Commvault
$61.31 /

-14.255 (-18.87%)

CVLT Commvault
$61.31 /

-14.255 (-18.87%)

Recommendations
Masimo price target raised to $320 from $300 at Piper Sandler » 04:56
10/27/21
10/27
04:56
10/27/21
04:56
MASI

Masimo

$289.16 /

+3.695 (+1.29%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MASI Masimo
$289.16 /

+3.695 (+1.29%)

MASI Masimo
$289.16 /

+3.695 (+1.29%)

10/12/21 Raymond James
Masimo resumed with a Market Perform at Raymond James
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
07/28/21 Piper Sandler
Masimo price target raised to $300 from $295 at Piper Sandler
07/01/21 Piper Sandler
Masimo ITC request may signal push into consumer products, says Piper Sandler
MASI Masimo
$289.16 /

+3.695 (+1.29%)

MASI Masimo
$289.16 /

+3.695 (+1.29%)

Conference/Events
High Tide management to meet virtually with Roth Capital » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
HITI

High Tide

$5.32 /

-0.12 (-2.21%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HITI High Tide
$5.32 /

-0.12 (-2.21%)

HITI High Tide
$5.32 /

-0.12 (-2.21%)

10/22/21 Desjardins
High Tide price target lowered to C$13.50 from C$15 at Desjardins
10/07/21 Roth Capital
Roth Capital views High Tide acquisition of Blessed CBD 'favorably'
09/13/21 Roth Capital
High Tide initiated with a Buy rating at Roth Capital
09/02/21 Desjardins
High Tide initiated with a Buy at Desjardins
HITI High Tide
$5.32 /

-0.12 (-2.21%)

HITI High Tide
$5.32 /

-0.12 (-2.21%)

Conference/Events
Gamida Cell management to meet virtually with Piper Sandler » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
GMDA

Gamida Cell

$3.92 /

-0.07 (-1.75%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GMDA Gamida Cell
$3.92 /

-0.07 (-1.75%)

GMDA Gamida Cell
$3.92 /

-0.07 (-1.75%)

05/11/21 Oppenheimer
Gamida Cell progressing toward omidubicel BLA, says Oppenheimer
05/11/21 JMP Securities
JMP Securities bullish on Gamida Cell, says regulatory preparedness on track
03/09/21 Piper Sandler
Gamida Cell price target lowered to $23 from $25 at Piper Sandler
02/10/21 H.C. Wainwright
Gamida Cell price target raised to $27 from $15 at H.C. Wainwright
GMDA Gamida Cell
$3.92 /

-0.07 (-1.75%)

Conference/Events
Datadog to host virtual investor meeting » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
DDOG

Datadog

$163.90 /

+2.25 (+1.39%)

Virtual Investor Meeting…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DDOG Datadog
$163.90 /

+2.25 (+1.39%)

DDOG Datadog
$163.90 /

+2.25 (+1.39%)

10/18/21 Mizuho
Datadog price target raised to $170 from $145 at Mizuho
10/14/21 RBC Capital
New Relic initiated with a Sector Perform at RBC Capital
09/17/21 Barclays
Datadog price target raised to $180 from $156 at Barclays
08/06/21 Truist
Datadog price target raised to $150 from $125 at Truist
DDOG Datadog
$163.90 /

+2.25 (+1.39%)

DDOG Datadog
$163.90 /

+2.25 (+1.39%)

DDOG Datadog
$163.90 /

+2.25 (+1.39%)

Conference/Events
Sprinklr management to meet virtually with William Blair » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
CXM

Sprinklr

$17.58 /

-0.59 (-3.25%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CXM Sprinklr
$17.58 /

-0.59 (-3.25%)

CXM Sprinklr
$17.58 /

-0.59 (-3.25%)

09/20/21 KeyBanc
Sprout Social price target raised to $153 from $112 at KeyBanc
09/10/21 Barclays
Sprinklr price target raised to $27 from $26 at Barclays
07/19/21 JPMorgan
Sprinklr initiated with a Neutral at JPMorgan
07/19/21 William Blair
Sprinklr initiated with an Outperform at William Blair
CXM Sprinklr
$17.58 /

-0.59 (-3.25%)

  • 23
    Jun
CXM Sprinklr
$17.58 /

-0.59 (-3.25%)

Conference/Events
Crocs management to meet virtually with Piper Sandler » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
CROX

Crocs

$154.22 /

-1.38 (-0.89%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CROX Crocs
$154.22 /

-1.38 (-0.89%)

CROX Crocs
$154.22 /

-1.38 (-0.89%)

10/25/21 UBS
Crocs price target raised to $175 from $157 at UBS
10/22/21 Stifel
Crocs price target raised to $157 from $151 at Stifel
10/21/21 Baird
Crocs price target raised to $250 from $215 at Baird
10/21/21 Baird
Baird names Crocs as Fresh Pick, ups price target to $250 from $215
CROX Crocs
$154.22 /

-1.38 (-0.89%)

CROX Crocs
$154.22 /

-1.38 (-0.89%)

CROX Crocs
$154.22 /

-1.38 (-0.89%)

CROX Crocs
$154.22 /

-1.38 (-0.89%)

Conference/Events
Aqua Metals to host investor webcast » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
AQMS

Aqua Metals

$1.95 /

+ (+0.00%)

Aqua Metals Investor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AQMS Aqua Metals
$1.95 /

+ (+0.00%)

AQMS Aqua Metals
$1.95 /

+ (+0.00%)

03/05/21 H.C. Wainwright
Aqua Metals initiated with a Buy at H.C. Wainwright
AQMS Aqua Metals
$1.95 /

+ (+0.00%)

Conference/Events
Truist Financial management to meet with Stephens » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
TFC

Truist Financial

$64.42 /

-0.15 (-0.23%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TFC Truist Financial
$64.42 /

-0.15 (-0.23%)

TFC Truist Financial
$64.42 /

-0.15 (-0.23%)

10/22/21 Raymond James
Marsh McLennan upgraded to Outperform from Underperform at Raymond James
10/11/21 Jefferies
Truist Financial price target raised to $66 from $61 at Jefferies
10/05/21 Wolfe Research
Truist downgraded to Underperform from Outperform at Wolfe Research
10/01/21 Citi
Truist Financial upgraded to Buy from Neutral at Citi
TFC Truist Financial
$64.42 /

-0.15 (-0.23%)

TFC Truist Financial
$64.42 /

-0.15 (-0.23%)

Conference/Events
American Society for Radiation Oncology to hold annual meeting » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
ARAY

Accuray

$4.31 /

-0.08 (-1.82%)

, NVS

Novartis

$84.84 /

+1.49 (+1.79%)

, AZN

AstraZeneca

$62.29 /

+0.54 (+0.87%)

, BAYRY

Bayer

$14.20 /

+0.04 (+0.28%)

, BD

Budget Group

/

+

, BIOC

Biocept

$3.76 /

-0.08 (-2.08%)

, BSX

Boston Scientific

$44.32 /

-0.17 (-0.38%)

, BMY

Bristol-Myers

$58.24 /

+0.47 (+0.81%)

, EKTAY

Elekta

$11.58 /

+0.09 (+0.78%)

, GRTX

Galera Therapeutics

$1.88 /

+0.04 (+2.17%)

, DNA

Ginkgo Bioworks

$14.46 /

+0.19 (+1.33%)

, HTHIY

Hitachi

$118.77 /

-0.71 (-0.59%)

, MRK

Merck

$82.23 /

+0.545 (+0.67%)

, MYGN

Myriad Genetics

$30.66 /

-1.81 (-5.57%)

, NBTX

Nanobiotix

$12.35 /

-0.3 (-2.37%)

, NNOX

Nano-X Imaging

$22.54 /

-0.55 (-2.38%)

, NTRA

Natera

$115.95 /

+0.2 (+0.17%)

, NVCR

Novocure

$113.51 /

-5.91 (-4.95%)

, PHG

Philips

$47.69 /

-0.12 (-0.25%)

, REGN

Regeneron

$592.37 /

+16.45 (+2.86%)

, SNY

Sanofi

$49.98 /

+0.125 (+0.25%)

, SGEN

Seagen

$177.70 /

+2.29 (+1.31%)

, SMMNY

Siemens Healthineers

$34.66 /

-0.07 (-0.20%)

, SYK

Stryker

$273.25 /

+0.08 (+0.03%)

, TDY

Teledyne

$437.11 /

-7.89 (-1.77%)

, VRAY

ViewRay

$6.96 /

-0.05 (-0.71%)

, VREX

Varex Imaging

$26.36 /

-0.7 (-2.59%)

63rd Annual ASTRO Meeting…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARAY Accuray
$4.31 /

-0.08 (-1.82%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

BIOC Biocept
$3.76 /

-0.08 (-2.08%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

EKTAY Elekta
$11.58 /

+0.09 (+0.78%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

HTHIY Hitachi
$118.77 /

-0.71 (-0.59%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

NBTX Nanobiotix
$12.35 /

-0.3 (-2.37%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

NTRA Natera
$115.95 /

+0.2 (+0.17%)

NVCR Novocure
$113.51 /

-5.91 (-4.95%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

SNY Sanofi
$49.98 /

+0.125 (+0.25%)

SGEN Seagen
$177.70 /

+2.29 (+1.31%)

SMMNY Siemens Healthineers
$34.66 /

-0.07 (-0.20%)

SYK Stryker
$273.25 /

+0.08 (+0.03%)

TDY Teledyne
$437.11 /

-7.89 (-1.77%)

VRAY ViewRay
$6.96 /

-0.05 (-0.71%)

ARAY Accuray
$4.31 /

-0.08 (-1.82%)

10/26/21 Lake Street
Investors should buy Accuray after 'excellent' ASTRO meeting, says Lake Street
05/24/21
Accuray management to meet virtually with Lake Street
01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
NVS Novartis
$84.84 /

+1.49 (+1.79%)

10/12/21 Berenberg
Novartis price target lowered to CHF 88 from CHF 96 at Berenberg
10/08/21 UBS
Novartis price target lowered to CHF 92 from CHF 95 at UBS
09/29/21 Stifel
Blueprint Medicines rersumed with a Hold at Stifel
09/20/21 Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

10/19/21 UBS
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS
10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

10/21/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
08/09/21 Berenberg
Bayer price target lowered to EUR 60 from EUR 74 at Berenberg
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
BD Budget Group
/

+

BIOC Biocept
$3.76 /

-0.08 (-2.08%)

10/08/21 Brookline
Biocept assumed with a Buy at Brookline
BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

10/06/21 Piper Sandler
Boston Scientific acquisition of Baylis looks 'solid,' says Piper Sandler
09/22/21 Piper Sandler
Boston Scientific said unlikely to hit low end of Q3 sales outlook, notes Piper
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
10/25/21 SVB Leerink
Potential Bristol takeover of Aurinia makes strategic sense, says SVB Leerink
10/25/21 Citi
Bristol-Myers report of Aurinia approach 'looks credible,' says Citi
10/12/21 Morgan Stanley
Bristol-Myers price target lowered to $66 from $71 at Morgan Stanley
EKTAY Elekta
$11.58 /

+0.09 (+0.78%)

08/27/21 JPMorgan
Elekta price target raised to SEK 95 from SEK 91 at JPMorgan
06/02/21 JPMorgan
Elekta price target raised to SEK 91 from SEK 82 at JPMorgan
04/27/21 JPMorgan
Elekta price target raised to SEK 82 from SEK 80 at JPMorgan
03/18/21 JPMorgan
Elekta downgraded to Underweight from Neutral at JPMorgan
GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

10/21/21 Citi
Galera Therapeutics price target lowered to $11 from $21 at Citi
10/20/21 H.C. Wainwright
Galera Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/19/21 BofA
Galera double downgraded to Underperform at BofA after ROMAN trial miss
10/19/21 BofA
Galera Therapeutics downgraded to Underperform from Buy at BofA
DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

10/20/21 Raymond James
Raymond James expects more equity-based payments for Ginkgo as milestones met
10/13/21 Raymond James
Ginkgo Bioworks initiated with an Outperform at Raymond James
10/12/21 William Blair
Blair starts Ginkgo at Outperform on 'significant' competitive advantage
10/12/21 William Blair
Ginkgo Bioworks initiated with an Outperform at William Blair
HTHIY Hitachi
$118.77 /

-0.71 (-0.59%)

11/20/20 Goldman Sachs
Hitachi reinstated with a Sell at Goldman Sachs
MRK Merck
$82.23 /

+0.545 (+0.67%)

10/22/21 SVB Leerink
Merck price target raised to $105 from $104 at SVB Leerink
10/19/21 Roth Capital
Enanta drug 'naturally more potent' than Merck's antiviral, says Roth Capital
10/19/21 Evercore ISI
Atea's Phase 2 design disappoints, but drug has not failed, says Evercore ISI
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

10/14/21 Cowen
Myriad Genetics coverage transferred at Cowen
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Myriad Genetics initiated with a Market Perform at Raymond James
06/03/21 Goldman Sachs
Myriad Genetics initiated with a Sell at Goldman Sachs
NBTX Nanobiotix
$12.35 /

-0.3 (-2.37%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

04/19/21 Ladenburg
Ladenburg starts Nano-X Imaging at Buy with $52 price target
04/19/21 Ladenburg
Nano-X Imaging initiated with a Buy at Ladenburg
02/01/21 Cantor Fitzgerald
Cantor Fitzgerald reiterates Overweight on Nano-X Imaging, lowers target to $67
NTRA Natera
$115.95 /

+0.2 (+0.17%)

10/19/21 Canaccord
Natera Prospera Lung launch to continue momentum, says Canaccord
10/14/21 Cowen
Natera coverage transferred at Cowen
08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
08/09/21 Piper Sandler
Natera price target raised to $160 from $155 at Piper Sandler
NVCR Novocure
$113.51 /

-5.91 (-4.95%)

10/25/21 Piper Sandler
Novocure price target lowered to $195 from $235 at Piper Sandler
09/21/21 Piper Sandler
Novocure clinical update should come in next few weeks, says Piper Sandler
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
07/30/21 Mizuho
Novocure price target lowered to $200 from $229 at Mizuho
PHG Philips
$47.69 /

-0.12 (-0.25%)

10/25/21 Credit Suisse
Philips price target lowered to EUR 42 from EUR 49 at Credit Suisse
10/19/21 JPMorgan
Philips price target lowered to EUR 36.40 from EUR 40.90 at JPMorgan
10/19/21 Deutsche Bank
Philips price target lowered to EUR 42 from EUR 43 at Deutsche Bank
09/10/21 Barclays
Philips price target lowered to EUR 53 from EUR 54 at Barclays
REGN Regeneron
$592.37 /

+16.45 (+2.86%)

10/26/21 SVB Leerink
Regeneron price target raised to $798 from $785 at SVB Leerink
10/25/21 H.C. Wainwright
Regeneron trial data reinforce bullish outlook on Dupixent, says H.C. Wainwright
10/22/21 H.C. Wainwright
Regeneron price target raised to $842 from $831 at H.C. Wainwright
10/14/21 H.C. Wainwright
H.C. Wainwright 'enthusiastic' on Regeneron, sees no barrier for REGEN-COV nod
SNY Sanofi
$49.98 /

+0.125 (+0.25%)

10/25/21 H.C. Wainwright
Regeneron trial data reinforce bullish outlook on Dupixent, says H.C. Wainwright
10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
SGEN Seagen
$177.70 /

+2.29 (+1.31%)

10/14/21 BTIG
Seagen assumed with a Neutral at BTIG
09/27/21 RBC Capital
Seagen price target raised to $154 from $148 at RBC Capital
05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
SMMNY Siemens Healthineers
$34.66 /

-0.07 (-0.20%)

10/13/21 UBS
Siemens Healthineers price target raised to EUR 54 from EUR 48 at UBS
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold at Societe Generale
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold from Buy at Societe Generale
09/10/21 Barclays
Siemens Healthineers price target raised to EUR 55 from EUR 49 at Barclays
SYK Stryker
$273.25 /

+0.08 (+0.03%)

09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 SVB Leerink
Stryker price target raised to $300 from $290 at SVB Leerink
TDY Teledyne
$437.11 /

-7.89 (-1.77%)

07/30/21 Cowen
Teledyne price target raised to $525 from $500 at Cowen
06/08/21 Goldman Sachs
Teledyne reinstated with a Neutral at Goldman Sachs
05/25/21 BofA
Teledyne initiated with a Buy at BofA
04/29/21 Needham
Teledyne price target raised to $500 from $416 at Needham
VRAY ViewRay
$6.96 /

-0.05 (-0.71%)

10/19/21 Piper Sandler
ViewRay strength attributed to MIRAGE study recruiting halt, says Piper Sandler
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
06/25/21 Morgan Stanley
ViewRay upgraded to Equal Weight from Underweight at Morgan Stanley
VREX Varex Imaging
$26.36 /

-0.7 (-2.59%)

02/05/21 Oppenheimer
Varex Imaging upgraded to Outperform from Perform at Oppenheimer
ARAY Accuray
$4.31 /

-0.08 (-1.82%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

BIOC Biocept
$3.76 /

-0.08 (-2.08%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

NBTX Nanobiotix
$12.35 /

-0.3 (-2.37%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

NTRA Natera
$115.95 /

+0.2 (+0.17%)

NVCR Novocure
$113.51 /

-5.91 (-4.95%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

SNY Sanofi
$49.98 /

+0.125 (+0.25%)

SGEN Seagen
$177.70 /

+2.29 (+1.31%)

SYK Stryker
$273.25 /

+0.08 (+0.03%)

TDY Teledyne
$437.11 /

-7.89 (-1.77%)

VRAY ViewRay
$6.96 /

-0.05 (-0.71%)

VREX Varex Imaging
$26.36 /

-0.7 (-2.59%)

  • 22
    Jul
  • 11
    Feb
  • 22
    Jan
  • 05
    Jan
  • 11
    Dec
NVS Novartis
$84.84 /

+1.49 (+1.79%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

HTHIY Hitachi
$118.77 /

-0.71 (-0.59%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

SNY Sanofi
$49.98 /

+0.125 (+0.25%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

NTRA Natera
$115.95 /

+0.2 (+0.17%)

NVCR Novocure
$113.51 /

-5.91 (-4.95%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

SNY Sanofi
$49.98 /

+0.125 (+0.25%)

SGEN Seagen
$177.70 /

+2.29 (+1.31%)

SMMNY Siemens Healthineers
$34.66 /

-0.07 (-0.20%)

SYK Stryker
$273.25 /

+0.08 (+0.03%)

VREX Varex Imaging
$26.36 /

-0.7 (-2.59%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

TDY Teledyne
$437.11 /

-7.89 (-1.77%)

Conference/Events
Veeva to host investor day » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
VEEV

Veeva

$322.97 /

+1.245 (+0.39%)

Investor Day to be held…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VEEV Veeva
$322.97 /

+1.245 (+0.39%)

VEEV Veeva
$322.97 /

+1.245 (+0.39%)

10/01/21 Stifel
Veeva assumed with a Buy at Stifel
09/03/21 SVB Leerink
Veeva price target raised to $296 from $294 at SVB Leerink
09/02/21 UBS
Veeva price target raised to $320 from $270 at UBS
09/02/21 Baird
Veeva price target raised to $349 from $340 at Baird
VEEV Veeva
$322.97 /

+1.245 (+0.39%)

VEEV Veeva
$322.97 /

+1.245 (+0.39%)

Conference/Events
Datadog to host virtual investor meeting » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
DDOG

Datadog

$163.90 /

+2.25 (+1.39%)

Virtual Investor Meeting…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DDOG Datadog
$163.90 /

+2.25 (+1.39%)

DDOG Datadog
$163.90 /

+2.25 (+1.39%)

10/18/21 Mizuho
Datadog price target raised to $170 from $145 at Mizuho
10/14/21 RBC Capital
New Relic initiated with a Sector Perform at RBC Capital
09/17/21 Barclays
Datadog price target raised to $180 from $156 at Barclays
08/06/21 Truist
Datadog price target raised to $150 from $125 at Truist
DDOG Datadog
$163.90 /

+2.25 (+1.39%)

DDOG Datadog
$163.90 /

+2.25 (+1.39%)

DDOG Datadog
$163.90 /

+2.25 (+1.39%)

Conference/Events
Steelcase management to meet virtually with Benchmark » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
SCS

Steelcase

$12.39 /

-0.07 (-0.56%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCS Steelcase
$12.39 /

-0.07 (-0.56%)

SCS Steelcase
$12.39 /

-0.07 (-0.56%)

05/11/21 Berenberg
Berenberg starts 'market leader' Steelcase at Buy
05/11/21 Berenberg
Steelcase initiated with a Buy at Berenberg
05/07/21 Benchmark
Benchmark upgrades Steelcase to Buy on signs of recovery in commercial furniture
05/07/21 Benchmark
Steelcase upgraded to Buy from Hold at Benchmark
SCS Steelcase
$12.39 /

-0.07 (-0.56%)

SCS Steelcase
$12.39 /

-0.07 (-0.56%)

SCS Steelcase
$12.39 /

-0.07 (-0.56%)

Conference/Events
CollPlant management to meet virtually with B. Riley » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
CLGN

CollPlant

$22.50 /

+0.6 (+2.74%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLGN CollPlant
$22.50 /

+0.6 (+2.74%)

CLGN CollPlant
$22.50 /

+0.6 (+2.74%)

  • 12
    Feb
CLGN CollPlant
$22.50 /

+0.6 (+2.74%)

CLGN CollPlant
$22.50 /

+0.6 (+2.74%)

Conference/Events
Nano-X Imaging to host virtual event » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
NNOX

Nano-X Imaging

$22.54 /

-0.55 (-2.38%)

Nanox Live Streaming AI…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

04/19/21 Ladenburg
Ladenburg starts Nano-X Imaging at Buy with $52 price target
04/19/21 Ladenburg
Nano-X Imaging initiated with a Buy at Ladenburg
02/01/21 Cantor Fitzgerald
Cantor Fitzgerald reiterates Overweight on Nano-X Imaging, lowers target to $67
NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

  • 11
    Feb
NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

Conference/Events
Genius Brands to host business news update conference call » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
GNUS

Genius Brands

$1.86 /

-0.17 (-8.37%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNUS Genius Brands
$1.86 /

-0.17 (-8.37%)

GNUS Genius Brands
$1.86 /

-0.17 (-8.37%)

GNUS Genius Brands
$1.86 /

-0.17 (-8.37%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.